Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review
Authors
Keywords
-
Journal
BIODRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-02
DOI
10.1007/s40259-023-00632-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle
- (2023) Adrien Morin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dystrophin Immunity after Gene Therapy for Duchenne’s Muscular Dystrophy
- (2023) Carsten G. Bönnemann et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR‒Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein
- (2023) Tatiana V. Egorova et al. Molecular Therapy-Methods & Clinical Development
- Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy
- (2022) Nathalie Bourg et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression
- (2022) Anna V. Starikova et al. Scientific Reports
- Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
- (2022) Arianna Manini et al. Frontiers in Neurology
- Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations
- (2022) Jerry R. Mendell et al. Molecular Therapy-Methods & Clinical Development
- Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
- (2022) Cedric Happi Mbakam et al. Frontiers in Medicine
- Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression
- (2022) Angelina M. Georgieva et al. Nature Communications
- Drug development progress in duchenne muscular dystrophy
- (2022) Jiexin Deng et al. Frontiers in Pharmacology
- Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
- (2022) Britt Hanson et al. Molecular Therapy-Nucleic Acids
- Phosphorylation alters the mechanical stiffness of a model fragment of the dystrophin homologue utrophin
- (2022) Maria Paz Ramirez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
- (2021) Anna Rugowska et al. Clinical Epigenetics
- Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy
- (2021) Rebecca J. Willcocks et al. JAMA Network Open
- Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
- (2021) Vratko Himič et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Efficient Correction of Duchenne Muscular Dystrophy Mutations by SpCas9 and Dual gRNAs
- (2021) Xi Xiang et al. Molecular Therapy-Nucleic Acids
- Duchenne muscular dystrophy
- (2021) Dongsheng Duan et al. Nature Reviews Disease Primers
- Concerns Regarding Therapeutic Implications of Very Low‐Level Dystrophin
- (2021) Eric P. Hoffman et al. ANNALS OF NEUROLOGY
- Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
- (2021) Alicja Starosta et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Casimersen: First Approval
- (2021) Matt Shirley DRUGS
- RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
- (2021) Zhichao Tang et al. MOLECULES
- Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
- (2021) Patricia Soblechero‐Martín et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength
- (2021) Paul T. Martin et al. PLoS One
- Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
- (2021) F. Chemello et al. Science Advances
- Full-length Dystrophin Restoration via Targeted Genomic Integration by AAV-CRISPR in a Humanized Mouse Model of Duchenne Muscular Dystrophy
- (2021) Adrian Pickar-Oliver et al. MOLECULAR THERAPY
- Safety, tolerability, and pharmacokinetics of casimersen in patients with D uchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial
- (2021) Kathryn R. Wagner et al. MUSCLE & NERVE
- Efficient precise in vivo base editing in adult dystrophic mice
- (2021) Li Xu et al. Nature Communications
- Dystrophin Dp71 Subisoforms Localize to the Mitochondria of Human Cells
- (2021) Emma Tabe Eko Niba et al. Life-Basel
- Gene Therapy for Duchenne Muscular Dystrophy
- (2021) Nertiyan Elangkovan et al. Journal of Neuromuscular Diseases
- Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases
- (2021) Yoshitsugu Aoki et al. Journal of Neuromuscular Diseases
- Life Expectancy in Duchenne Muscular Dystrophy
- (2021) Jonathan Broomfield et al. NEUROLOGY
- The Effect of Immunomodulatory Treatments on Anti-Dystrophin Immune Response After AAV Gene Therapy in Dystrophin Deficient mdx Mice
- (2021) Ning Li et al. Journal of Neuromuscular Diseases
- A Review of Deflazacort for Patients With Duchenne Muscular Dystrophy
- (2020) Mary Bylo et al. ANNALS OF PHARMACOTHERAPY
- Golodirsen: First Approval
- (2020) Young-A Heo DRUGS
- High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy
- (2020) Emanuele Loro et al. Scientific Reports
- Tissue-Specificity of Dystrophin–Actin Interactions: Isoform-Specific Thermodynamic Stability and Actin-Binding Function of Tandem Calponin-Homology Domains
- (2020) Vaibhav Upadhyay et al. ACS Omega
- Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
- (2020) Giuseppe Ronzitti et al. Frontiers in Immunology
- Viltolarsen: First Approval
- (2020) Sohita Dhillon DRUGS
- Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
- (2020) Salvatore Crisafulli et al. Orphanet Journal of Rare Diseases
- Dystrophin Dp71ab is monoclonally expressed in human satellite cells and enhances proliferation of myoblast cells
- (2020) Manal Farea et al. Scientific Reports
- Rapid, redox-mediated mechanical susceptibility of the cortical microtubule lattice in skeletal muscle
- (2020) D'anna M. Nelson et al. Redox Biology
- Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy
- (2020) Yvan Feraudy et al. ANNALS OF NEUROLOGY
- Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells
- (2020) Kasturi Sengupta et al. Molecular Therapy-Nucleic Acids
- CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering
- (2020) Maryam Saifaldeen et al. Cells
- Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles
- (2020) Niclas E. Bengtsson et al. MOLECULAR THERAPY
- Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy
- (2019) Kay E. Davies et al. MOLECULAR THERAPY
- Development of Novel Micro-dystrophins with Enhanced Functionality
- (2019) Julian N. Ramos et al. MOLECULAR THERAPY
- The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
- (2019) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- Therapeutic developments for Duchenne muscular dystrophy
- (2019) Ingrid E. C. Verhaart et al. Nature Reviews Neurology
- In Situ Modification of Tissue Stem and Progenitor Cell Genomes
- (2019) Jill M. Goldstein et al. Cell Reports
- AAV-based gene therapies for the muscular dystrophies
- (2019) Julie M Crudele et al. HUMAN MOLECULAR GENETICS
- What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?
- (2019) Dominic J. Wells JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
- Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function
- (2019) Junling Zhao et al. MOLECULAR MEDICINE
- Immunogenicity of Cas9 Protein
- (2019) Aditi Mehta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- How the central domain of dystrophin acts to bridge F-actin to sarcolemmal lipids
- (2019) Dominique Mias-Lucquin et al. JOURNAL OF STRUCTURAL BIOLOGY
- Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models
- (2019) Yafeng Song et al. NATURE MEDICINE
- Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy
- (2019) Michael Naidoo et al. MOLECULAR NEUROBIOLOGY
- Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice
- (2019) Buel D. Rodgers et al. Molecular Therapy-Methods & Clinical Development
- Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice
- (2018) Cinzia Pisani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy
- (2018) Tatianna Wai Ying Wong et al. CURRENT GENE THERAPY
- Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
- (2018) Kelly J. Perkins et al. FEBS LETTERS
- Syntrophin binds directly to multiple spectrin-like repeats in dystrophin and mediates binding of nNOS to repeats 16–17
- (2018) Marvin E Adams et al. HUMAN MOLECULAR GENETICS
- Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics
- (2018) Justin R. Fallon et al. MATRIX BIOLOGY
- Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
- (2018) Seuk-Min Ryu et al. NATURE BIOTECHNOLOGY
- Eteplirsen treatment for Duchenne muscular dystrophy
- (2018) Jay S. Charleston et al. NEUROLOGY
- The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy
- (2018) Simon Guiraud et al. Expert Opinion on Orphan Drugs
- Human Dystrophin Structural Changes upon Binding to Anionic Membrane Lipids
- (2018) Raphael Dos Santos Morais et al. BIOPHYSICAL JOURNAL
- CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo
- (2018) Benjamin L. Duchêne et al. MOLECULAR THERAPY
- Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy
- (2018) Peggy P. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- NS-065/NCNP-01: an Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy
- (2018) Naoki Watanabe et al. Molecular Therapy-Nucleic Acids
- Dystrophin As a Molecular Shock Absorber
- (2018) Shimin Le et al. ACS Nano
- CRISPR Correction of Duchenne Muscular Dystrophy
- (2018) Yi-Li Min et al. Annual Review of Medicine
- Perspective: Spectrin-Like Repeats in Dystrophin Have Unique Binding Preferences for Syntrophin Adaptors That Explain the Mystery of How nNOSμ Localizes to the Sarcolemma
- (2018) Justin M. Percival Frontiers in Physiology
- Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
- (2018) Tahnee L. Kennedy et al. Molecular Therapy-Methods & Clinical Development
- Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy
- (2017) Mikako Ito et al. HUMAN GENE THERAPY
- Normal and altered pre-mRNA processing in the DMD gene
- (2017) Sylvie Tuffery-Giraud et al. HUMAN GENETICS
- Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1
- (2017) Anna Majowicz et al. MOLECULAR THERAPY
- Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
- (2017) Leonela Amoasii et al. Science Translational Medicine
- Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
- (2017) Caroline Le Guiner et al. Nature Communications
- Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
- (2017) Niclas E. Bengtsson et al. Nature Communications
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction
- (2017) Manoj K. Mishra et al. PLoS One
- Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis
- (2017) Hung-Chih Chen et al. Scientific Reports
- Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders
- (2016) Daria Wojtal et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
- (2016) Courtney S. Young et al. Cell Stem Cell
- Independent variability of microtubule perturbations associated with dystrophinopathy
- (2016) Joseph J. Belanto et al. HUMAN MOLECULAR GENETICS
- Dystrophin contains multiple independent membrane-binding domains
- (2016) Junling Zhao et al. HUMAN MOLECULAR GENETICS
- CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
- (2016) Li Xu et al. MOLECULAR THERAPY
- Histological effects of givinostat in boys with Duchenne muscular dystrophy
- (2016) Paolo Bettica et al. NEUROMUSCULAR DISORDERS
- Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
- (2016) Jean-Paul Iyombe-Engembe et al. Molecular Therapy-Nucleic Acids
- Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells
- (2016) Ignazio Maggio et al. Scientific Reports
- Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies
- (2015) Yingyin Liang et al. Bosnian Journal of Basic Medical Sciences
- Viral vector-mediated gene therapies
- (2015) Katrin Hollinger et al. CURRENT OPINION IN NEUROLOGY
- Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success—A Personal Perspective
- (2015) Eric Hastie et al. HUMAN GENE THERAPY
- Second-generation compound for the modulation of utrophin in the therapy of DMD
- (2015) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Structural Basis of Neuronal Nitric-oxide Synthase Interaction with Dystrophin Repeats 16 and 17
- (2015) Anne-Elisabeth Molza et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers
- (2015) Jon Tinsley et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
- (2015) Aurélie Goyenvalle et al. NATURE MEDICINE
- Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division
- (2015) Nicolas A Dumont et al. NATURE MEDICINE
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- I-TASSER server: new development for protein structure and function predictions
- (2015) Jianyi Yang et al. NUCLEIC ACIDS RESEARCH
- Abnormal splicing switch of DMD’s penultimate exon compromises muscle fibre maintenance in myotonic dystrophy
- (2015) Frédérique Rau et al. Nature Communications
- Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
- (2015) David G. Ousterout et al. Nature Communications
- Gene therapy for Duchenne muscular dystrophy
- (2015) Julian Ramos et al. Expert Opinion on Orphan Drugs
- Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
- (2015) Hongmei Lisa Li et al. Stem Cell Reports
- Nucleocytoplasmic shuttling of the Duchenne muscular dystrophy gene product dystrophin Dp71d is dependent on the importin α/β and CRM1 nuclear transporters and microtubule motor dynein
- (2014) R. Suárez-Sánchez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Ataluren: First Global Approval
- (2014) Nicola J. Ryan DRUGS
- Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting
- (2014) Kristy Swiderski et al. HUMAN MOLECULAR GENETICS
- The role of nNOS and PGC-1 in skeletal muscle cells
- (2014) S. Baldelli et al. JOURNAL OF CELL SCIENCE
- Dystrobrevin increases dystrophin's binding to the dystrophin–glycoprotein complex and provides protection during cardiac stress
- (2014) Jana Strakova et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Ataluren treatment of patients with nonsense mutation dystrophinopathy
- (2014) Katharine Bushby et al. MUSCLE & NERVE
- Microtubule binding distinguishes dystrophin from utrophin
- (2014) J. J. Belanto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
- (2014) C. Long et al. SCIENCE
- Skipping Multiple Exons of Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
- (2014) Yusuke Echigoya et al. Nucleic Acid Therapeutics
- Adeno-associated viral vectors do not efficiently target muscle satellite cells
- (2014) Andrea LH Arnett et al. Molecular Therapy-Methods & Clinical Development
- Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice
- (2013) Maaike van Putten et al. FASEB JOURNAL
- Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin α2 Surrogates
- (2013) Louis G. Chicoine et al. MOLECULAR THERAPY
- Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
- (2013) LG Chicoine et al. MOLECULAR THERAPY
- Cas9 as a versatile tool for engineering biology
- (2013) Prashant Mali et al. NATURE METHODS
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
- (2013) Rebecca J. Fairclough et al. NATURE REVIEWS GENETICS
- Identification of New Dystroglycan Complexes in Skeletal Muscle
- (2013) Eric K. Johnson et al. PLoS One
- Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
- (2013) Richard S. Finkel et al. PLoS One
- Resisting sarcolemmal rupture: dystrophin repeats increase membrane-actin stiffness
- (2012) Joe Sarkis et al. FASEB JOURNAL
- Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse
- (2012) Gaynor Miller et al. HUMAN MOLECULAR GENETICS
- The Shortest Isoform of Dystrophin (Dp40) Interacts with a Group of Presynaptic Proteins to Form a Presumptive Novel Complex in the Mouse Brain
- (2012) Takenori Tozawa et al. MOLECULAR NEUROBIOLOGY
- Nitric oxide synthases: regulation and function
- (2011) U. Forstermann et al. EUROPEAN HEART JOURNAL
- Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice
- (2011) Luke M. Judge et al. HUMAN MOLECULAR GENETICS
- The Role of Alpha-Dystrobrevin in Striated Muscle
- (2011) Masayuki Nakamori et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical progression of X-linked muscular dystrophy in two German Shorthaired Pointers
- (2011) Natasha J. Olby et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
- (2011) Brian Bostick et al. MOLECULAR THERAPY
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
- (2011) Dawn E Bowles et al. MOLECULAR THERAPY
- Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
- (2011) Jonathon M. Tinsley et al. PLoS One
- Ankyrin-B Interactions with Spectrin and Dynactin-4 Are Required for Dystrophin-based Protection of Skeletal Muscle from Exercise Injury
- (2010) Gai Ayalon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dystrophins, Utrophins, and Associated Scaffolding Complexes: Role in Mammalian Brain and Implications for Therapeutic Strategies
- (2010) Caroline Perronnet et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin
- (2010) D. Li et al. JOURNAL OF CELL SCIENCE
- Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6
- (2010) Guy L Odom et al. MOLECULAR THERAPY
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice
- (2010) A. R. Amenta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Polyproline Site in Hinge 2 Influences the Functional Capacity of Truncated Dystrophins
- (2010) Glen B. Banks et al. PLoS Genetics
- The neurobiology of the dystrophin-associated glycoprotein complex
- (2009) Adrian Waite et al. ANNALS OF MEDICINE
- The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b
- (2009) Kazunari Yamashita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice
- (2009) Maria Grazia Di Certo et al. HUMAN MOLECULAR GENETICS
- Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
- (2009) Yi Lai et al. JOURNAL OF CLINICAL INVESTIGATION
- The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin
- (2009) Jung Hae Yoon et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan
- (2008) Gai Ayalon et al. CELL
- Deregulated Protein Kinase A Signaling and Myospryn Expression in Muscular Dystrophy
- (2008) Joseph G. Reynolds et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Microutrophin Delivery Through rAAV6 Increases Lifespan and Improves Muscle Function in Dystrophic Dystrophin/Utrophin-deficient Mice
- (2008) Guy L Odom et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search